FAQs
Glossary

Close

FAQs

Why are some conditions more suitable for gene and cell therapies than others?

There is an approved treatment available for my condition - why can't I receive it?

How to look for approved medicines?

How are medicines developed and approved?

Close

Glossary

Adeno-associated virus (AAV)

Adult stem cells

Advanced Therapy Investigational Medicinal Product (ATIMP)

Advanced Therapy Medicinal Product (ATMP)

See full Glossary

Improving patient access to gene and cell therapies for rare diseases in Europe.

In this report, EURODIS reviews the challenges and proposals for improving patient access to advanced therapeutic medicinal products in England.

Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts